Global Albumin (as Excipient) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Albumin (as Excipient) Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries.
Albumin (as Excipient) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Albumin (as Excipient) market is projected to reach US$ 6601.7 million in 2034, increasing from US$ 4340.4 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2034. Demand from Cell Culture Media and Medical Supplements are the major drivers for the industry.
The industry's leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.
By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Albumin (as Excipient) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
Segment by Type
Human Serum Albumin
Recombinant Albumin
Cell Culture Media
Medical Supplements
Therapeutics
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Albumin (as Excipient) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Albumin (as Excipient), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Albumin (as Excipient) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Albumin (as Excipient) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Albumin (as Excipient) introduction, etc. Albumin (as Excipient) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Albumin (as Excipient) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Albumin (as Excipient) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Albumin (as Excipient) market is projected to reach US$ 6601.7 million in 2034, increasing from US$ 4340.4 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2034. Demand from Cell Culture Media and Medical Supplements are the major drivers for the industry.
The industry's leading manufacturers are Grifols, CSL and Takeda, which accounted for 20.39%, 15.19% and 14.36% of global revenues in 2019.
By region, Asia-Pacific is the largest consumption market of Albumin (as Excipient), with its sales volume at 70.83%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Albumin (as Excipient) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
Segment by Type
Human Serum Albumin
Recombinant Albumin
Segment by Application
Cell Culture Media
Medical Supplements
Therapeutics
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Albumin (as Excipient) market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Albumin (as Excipient), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Albumin (as Excipient) industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Albumin (as Excipient) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Albumin (as Excipient) introduction, etc. Albumin (as Excipient) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Albumin (as Excipient) market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices